-

20/20 Onsite Executives Recognized for Global Business Achievements in the 2024 TITAN Women In Business Awards

BOSTON--(BUSINESS WIRE)--20/20 Onsite is proud to announce that two of its executives, Sonali Bloom, CEO, and Jessica McKenzie Mays, Vice President of Life Sciences, have been named 2024 Female Executives of the Year by the TITAN Women in Business Awards, presented by the International Awards Associate (IAA). Bloom received the Platinum Award for CEO of the Year, while McKenzie Mays was honored with the Platinum Award for Innovative Executive of the Year. These prestigious awards recognize their remarkable leadership and accomplishments in the business industry.

Thanks to their direction, Bloom and McKenzie Mays have advanced the 20/20 Onsite mission of transforming clinical research by delivering eye care directly to the point of need. Their innovative work in decentralized trials, enabling point-of-need eye assessments through mobile clinics, has improved patient access and clinical outcomes, positioning 20/20 Onsite as a trusted partner for life sciences companies nationwide.

Throughout this highly competitive year, the TITAN Women In Business Awards has drawn hundreds of impressive entries from countries including the United States, Australia, Canada, United Kingdom, Singapore, Switzerland, Germany, and more. Bloom and McKenzie Mays showcased groundbreaking achievements that are now being recognized and celebrated across the global business community.

Please view the view the dedicated Winner’s Pages:

“This award is a reflection of the entire 20/20 Onsite team’s dedication to transforming healthcare - from front-line primary care to clinical trials. Our work in clinical research isn’t just about improving trial outcomes—it’s about reducing delays and gaps in access to critical ophthalmic assessments and therapeutics. I’m proud to lead a group so committed to making a real impact in healthcare.”

- Sonali Bloom, CEO, 20/20 Onsite

"While our business may be niche, providing point-of-need ophthalmic assessments in clinical trials, we’re part of a larger movement to address gaps and inequities in healthcare access across the U.S. I believe this work has far-reaching applications across the entire healthcare ecosystem, and I’m excited for our next chapter of growth. This award is more than just a personal achievement; it’s a testament to the incredible work our whole team is doing to reshape the future of clinical research."

- Jessica McKenzie Mays, Vice President of Life Sciences, 20/20 Onsite

About 20/20 Onsite
20/20 Onsite is a healthcare services company providing clinical trial solutions that are transforming the delivery of vision care by radically improving access for patients through state-of-the-art Mobile Vision Clinics. Their integrated point-of-need service delivery platform has taken high-value ophthalmic assessments and eye-related services directly to patients at work, at school, in neighborhoods, and at clinical research sites. They are enabling and accelerating fundamental trends toward the consumerization of care and the decentralization of clinical trials.

20/20 Onsite has served over 80,000 patients, including 18 clinical trials, met 100% of screening timelines across their operations, and consistently reports patient NPS scores of over 93.

Visit their website: https://www.2020onsite.com/

About TITAN Women in Business Awards
The TITAN Women In Business Awards program recognizes, acknowledges, and celebrates women with outstanding achievements, displaying personal calibers of confidence, optimism, ambition and integrity in the ever-expansive business industry. The award extends welcoming arms to symbols of female accomplishments, advocates of SMEs or large organizations, and all who represent the female community across every industry within the market.

Contacts

Media Contact:
Josh Anderson, Janderson@2020onsite.com

20/20 Onsite


Release Versions

Contacts

Media Contact:
Josh Anderson, Janderson@2020onsite.com

Social Media Profiles
More News From 20/20 Onsite

20/20 Onsite Expands Mobile Vision Fleet, Strengthening Nationwide Reach and Clinical Trial Support Capacity

BOSTON--(BUSINESS WIRE)--20/20 Onsite, the leading provider of point-of-need ophthalmic services for clinical trials, announces the deployment of its latest mobile vision clinic, bringing its fleet to 16 units, including a mix of mobile clinics, pods, and suites. The new unit hit the road in early May and is now fully operational, enabling 20/20 Onsite to support a higher tempo of decentralized and hybrid clinical trials nationwide. This milestone reinforces 20/20 Onsite’s ability to scale with...

20/20 Onsite Recognized by TITAN Health Awards for Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments

BOSTON--(BUSINESS WIRE)--20/20 Onsite has been named a Silver Winner in the 2025 TITAN Health Awards in Provider & Services - Healthcare....

20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support

BOSTON--(BUSINESS WIRE)--20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around....
Back to Newsroom